Atypical skin manifestations during immune checkpoint blockage in coronavirus disease 2019–infected patients with lung cancer

A new coronavirus, named severe acute respiratory syndrome–coronavirus-2 by the WHO, has rapidly spread around the world since its first reported case in late December of 2019 from Wuhan, the People’s Republic of China. As of mid-April 2020, this virus has affected more than 180 countries and territ...

Full description

Autores:
Rolfo, Christian
Cardona-Mendoza, Andrés Felipe
Ruiz-Patiño, Alejandro
Ariza, Santiago
Zatarain-Barron, Lucia
Pino, Luis E.
Viola Muñoz, Lucía
Russo, Alessandro
Rojas Puentes, Leonardo
Ricaurte, Luisa
Arrieta, Oscar
Tipo de recurso:
Article of journal
Fecha de publicación:
2020
Institución:
Universidad El Bosque
Repositorio:
Repositorio U. El Bosque
Idioma:
spa
OAI Identifier:
oai:repositorio.unbosque.edu.co:20.500.12495/4619
Acceso en línea:
http://hdl.handle.net/20.500.12495/4619
https://doi.org/10.1016/j.jtho.2020.06.019
https://repositorio.unbosque.edu.co
Palabra clave:
Anti–PD-1 therapy
COVID-19
Lung cancer
Erythema multiforme
Urticarial
Vasculitis
Rights
openAccess
License
Acceso abierto